Correlation Between Pmv Pharmaceuticals and Organon

Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Organon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Organon into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pmv Pharmaceuticals and Organon Co, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Organon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Organon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Organon.

Diversification Opportunities for Pmv Pharmaceuticals and Organon

-0.11

Correlation Coefficient

Pmv Pharmaceuticals  Organon

Good diversification

The 3 months correlation between Pmv and Organon is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Organon Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organon and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Organon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organon has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Organon go up and down completely randomly.

Pair Corralation between Pmv Pharmaceuticals and Organon

Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to under-perform the Organon. But the stock apears to be less risky and, when comparing its historical volatility, Pmv Pharmaceuticals is 1.16 times less risky than Organon. The stock trades about -0.09 of its potential returns per unit of risk. The Organon Co is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  1,459  in Organon Co on November 19, 2024 and sell it today you would earn a total of  69.00  from holding Organon Co or generate 4.73% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Pmv Pharmaceuticals  vs.  Organon Co

Pmv Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pmv Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest unfluctuating performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Organon

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Organon Co are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very sluggish technical and fundamental indicators, Organon may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Pair Trading with Pmv Pharmaceuticals and Organon

The main advantage of trading using opposite Pmv Pharmaceuticals and Organon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Organon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organon will offset losses from the drop in Organon's long position.

The idea behind Pmv Pharmaceuticals and Organon Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.